GMRE:NYE-Global Medical REIT Inc (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 7.7

Change

+0.10 (+1.32)%

Market Cap

N/A

Volume

0.97M

Analyst Target

USD 14.79
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-07 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+0.19 (+0.15%)

USD 77.61B
VTR Ventas Inc

+0.17 (+0.30%)

USD 24.65B
DOC Healthpeak Properties Inc

-0.11 (-0.55%)

USD 14.07B
CTRE CareTrust REIT Inc.

+0.04 (+0.15%)

USD 5.07B
AHR American Healthcare REIT, Inc.

-0.10 (-0.36%)

USD 4.36B
NHI National Health Investors Inc

+0.15 (+0.22%)

USD 3.17B
LTC LTC Properties Inc

+0.68 (+2.03%)

USD 1.59B
CHCT Community Healthcare Trust Inc

-0.03 (-0.16%)

USD 0.52B
UHT Universal Health Realty Income..

-0.20 (-0.55%)

USD 0.51B
GMRE-PA Global Medical REIT Inc

-0.06 (-0.22%)

USD 0.40B

ETFs Containing GMRE

KBWY Invesco KBW Premium Yield.. 0.00 % 0.35 %

-0.13 (0%)

USD 0.23B
SDEF 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.26% 87% B+ 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.26% 87% B+ 31% F
Trailing 12 Months  
Capital Gain -28.31% 7% C- 8% B-
Dividend Return 7.82% 79% B- 85% B
Total Return -20.48% 7% C- 9% A-
Trailing 5 Years  
Capital Gain -42.75% 38% F 12% F
Dividend Return 30.78% 69% C- 83% B
Total Return -11.97% 31% F 19% F
Average Annual (5 Year Horizon)  
Capital Gain -4.46% 44% F 13% F
Dividend Return 2.19% 44% F 32% F
Total Return 6.66% 81% B- 91% A-
Risk Return Profile  
Volatility (Standard Deviation) 25.01% 38% F 44% F
Risk Adjusted Return 8.77% 44% F 26% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.